Blister vs Bottle for Chewable and Orodispersible Tablets


Published on 03/05/2026

Comparative Analysis of Blister and Bottle Packaging for Chewable and Orodispersible Tablets

In the pharmaceutical manufacturing landscape, the choice between blister and bottle packaging can significantly affect product integrity, patient adherence, and overall supply chain efficiency. This article explores a realistic scenario where a mid-sized pharmaceutical company faces challenges with product quality due to inappropriate packaging decisions. Readers will learn how to systematically detect, contain, investigate, and resolve issues related to blister and bottle packaging choices.

By walking through this case study, professionals in manufacturing, quality control, regulatory, and engineering functions will be better equipped to make informed packaging decisions that align with stringent regulatory expectations.

Symptoms/Signals on the Floor or in the Lab

In our scenario, a quality control laboratory identified unexpected dissolution failures for a batch of chewable tablets packaged in HDPE bottles with desiccant canisters. The specific symptoms noted included:

  • Higher than acceptable dissolution times exceeding the established specifications.
  • Visual inspection of tablets showed excessive moisture absorption.
  • Increased customer complaints about product effectiveness and quality.

Additionally, environmental monitoring data revealed elevated humidity levels in the

storage area, raising questions about the moisture barrier integrity of the packaging solution. These signals indicated a potential packaging failure directly impacting product quality.

Likely Causes (by category: Materials, Method, Machine, Man, Measurement, Environment)

Understanding the root causes of packaging failures is essential. In this case, investigations should cover the following categories:

  • Materials: Analyze the moisture barrier properties of HDPE bottles versus alu-alu blisters. Are the materials suitable for the active ingredients and formulations?
  • Method: Review the packaging method used. Was the sealing process appropriate for maintaining the integrity of the moisture barrier?
  • Machine: Evaluate the performance of packaging machinery. Did any settings or calibration issues contribute to compromised seals?
  • Man: Assess whether operator training and compliance with SOPs could have been factors in packaging consistency.
  • Measurement: Ensure that the monitoring equipment for humidity is correctly calibrated and functioning as intended.
  • Environment: Investigate whether the storage conditions prior to testing were appropriate to maintain product integrity.
Pharma Tip:  How to Use Complaint Trends to Reassess Blister vs Bottle Choices

Immediate Containment Actions (first 60 minutes)

Once the symptoms were detected, immediate containment actions were initiated to mitigate further impact:

  1. Quarantine the affected batch to prevent distribution and use.
  2. Conduct a rapid assessment of other batches packaged using the same method to check for similar issues.
  3. Notify all relevant stakeholders, including production and distribution teams, of the potential breach in quality.
  4. Begin environmental monitoring in the storage area focusing on humidity levels and temperature.
  5. Document all actions taken in real-time to ensure traceability and compliance with Good Manufacturing Practices (GMP).

Investigation Workflow (data to collect + how to interpret)

The investigation workflow for assessing the packaging-related issues should be methodical and comprehensive. The following data should be collected and reviewed:

  • Batch Records: Review all documentation related to the packaging process, including seals and environmental controls.
  • Dissolution Test Results: Gather historical dissolution data for comparison with the current batch.
  • Environmental Monitoring Logs: Analyze records for humidity and temperature in the storage area at the time of packaging and subsequent to that.
  • Material Specifications: Examine specifications for both the HDPE bottles and desiccant canisters used.

Once the data is collected, a trend analysis can be performed. Look for correlations such as increased humidity levels coinciding with reported failures. This analysis will assist in pinpointing where the deviations occurred.

Root Cause Tools (5-Why, Fishbone, Fault Tree) and when to use which

Several root cause analysis tools are applicable in our scenario:

  • 5-Why Analysis: This simple but effective technique can be used to explore the reasons for greater dissolution time. Start with the issue and ask “why” repeatedly until the root cause is identified.
  • Fishbone Diagram: Also known as a cause-and-effect diagram, the Fishbone diagram can help categorize potential causes related to materials, machines, methods, and environments. This is useful when brainstorming a wide range of potential issues.
  • Fault Tree Analysis: For more complex problems, such as understanding machine malfunctions, a Fault Tree analysis can model the different pathways that could lead to the failure.
Pharma Tip:  Blister vs Bottle for High-Humidity Markets: Stability and Cost Trade-Offs

By utilizing these tools, teams can arrive at a more comprehensive understanding of the underlying issues affecting product quality.

CAPA Strategy (correction, corrective action, preventive action)

Once root causes are identified, it is critical to develop a robust Corrective and Preventive Action (CAPA) strategy:

  • Correction: Implement immediate corrective actions, such as re-testing of the current batch with modified testing parameters.
  • Corrective Action: Make necessary adjustments to packaging methods. This may involve switching from HDPE bottles to alu-alu blisters for better moisture control.
  • Preventive Action: Revise training programs for operators regarding packaging protocols and environmental controls to ensure compliance and understanding.

Every action taken should be documented meticulously to provide evidence of compliance and continuous improvement.

Control Strategy & Monitoring (SPC/trending, sampling, alarms, verification)

To maintain the integrity of the chosen packaging solution, developing an effective control strategy is essential. This strategy may include:

Related Reads

  • Statistical Process Control (SPC): Implement SPC methods to monitor the packaging process continuously, enabling the identification of variations that could lead to failures.
  • Regular Sampling: Establish routine sampling and testing of batches to ensure consistent quality over time.
  • Alarm Systems: Utilize alarms for environmental conditions, ensuring deviations (e.g., humidity levels) trigger immediate investigations.
  • Verification Procedures: Conduct periodic verification of equipment used in packaging to ensure continuous adherence to specifications.

Validation / Re-qualification / Change Control impact (when needed)

Throughout this process, it may become necessary to conduct validation, re-qualification, or change control procedures:

  • With a packaging material change (from HDPE to alu-alu blisters), a full validation protocol should be initiated to ensure that the new packaging meets all functional requirements and regulatory expectations.
  • Any significant changes in packaging methods need to trigger a Change Control process to document and assess potential impacts on product quality.

Both validation and change control are essential to ensure compliance with regulatory standards and maintain product integrity throughout its lifecycle.

Inspection Readiness: what evidence to show (records, logs, batch docs, deviations)

In preparation for inspections by regulatory authorities, it is imperative to have a solid repository of evidence demonstrating compliance with established standards.

  • Batch Production Records: Ensure all batch records are completed accurately, with annotations of any issues encountered during packaging.
  • Environmental Monitoring Logs: Keep thorough logs demonstrating environmental controls that were maintained during production.
  • Deviations and CAPA Documentation: Document any deviations rigorously, along with associated CAPA actions taken to resolve issues.
  • Training Records: Maintain up-to-date training records for all personnel involved in packaging processes.
Pharma Tip:  Senior-Friendly Packaging: Blister or Bottle for Chronic Therapies?

Being thorough in documentation not only aids in inspections but fosters a quality-oriented culture within the organization.

FAQs

What are the main differences between blister and bottle packaging?

Blister packaging offers superior moisture protection and tactile feedback for adherence, while bottles are generally easier for patients to open and store.

How can moisture barrier properties of materials affect tablet quality?

Inadequate moisture barriers can lead to degradation of active ingredients, affecting the efficacy and safety of the product.

What is the significance of a desiccant canister in bottle packaging?

A desiccant canister absorbs excess moisture, helping to maintain tablet integrity and prolong shelf life within the bottle.

How often should we conduct environmental monitoring in the packaging area?

Routine environmental monitoring should coincide with production cycles and be further supplemented by re-evaluations during significant process changes.

Is operator training necessary for effective CAPA implementation?

Yes, ongoing training is essential for quick identification and appropriate responses to quality issues in manufacturing operations.

How does statistical process control help reduce risks in packaging?

SPC can identify trends that indicate potential failures, enabling corrective actions before products deviate from specifications.

When should a validation study be initiated following a packaging material change?

Validation should be initiated immediately after determining a new packaging material will be used to ensure it meets all regulatory and functional requirements.

What should be included in a change control document?

A change control document should outline the nature of the change, impact assessment, justification, and planned timelines for implementation and review.